Novartis' cancer treatment Kymriah gets Japan nod at cost of $305,800

A Japanese government panel approved Novartis' cancer treatment Kymriah at a price of 33.5 million yen ($305,800) on Wednesday, marking the entry of so-called CAR-T therapy in the country.